Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Reduction of PRC2 activity supports survival of TNBC cancer cells to cytotoxic treatments.


ABSTRACT: Basal-like breast cancer generally shows a good response to conventional cytotoxic but rapidly develops a resistant phenotype. To better understand the epigenetic changes underlying the acquisition of resistant properties, we treated the murine basal-like mammary carcinoma cell line G-2 for 48 hours with sublethal combination chemotherapy (Cyclophosphamide, Adriamycin, 5-Fluorouracil) and subsequently subjected them to RNA- and ChIP-sequencing.

INSTRUMENT(S): Illumina HiSeq 4000

ORGANISM(S): Mus musculus

SUBMITTER: Florian Wegwitz 

PROVIDER: E-MTAB-9584 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2022-07-31 | E-MTAB-11476 | biostudies-arrayexpress
2021-11-30 | E-MTAB-9547 | biostudies-arrayexpress
2022-08-31 | E-MTAB-10744 | biostudies-arrayexpress
2022-08-31 | E-MTAB-9589 | biostudies-arrayexpress
2022-09-01 | E-MTAB-11344 | biostudies-arrayexpress
2023-08-31 | E-MTAB-13117 | biostudies-arrayexpress
2023-08-31 | E-MTAB-13119 | biostudies-arrayexpress
2023-08-31 | E-MTAB-13120 | biostudies-arrayexpress
2015-09-15 | E-GEOD-71596 | biostudies-arrayexpress
2014-08-28 | E-GEOD-56984 | biostudies-arrayexpress